In a report published Monday, ROTH Capital analysts initiated coverage on Aduro Biotech, Inc. (ADRO) with a ‘Buy‘ rating and $74 price target, implying 72% expected return.
Since making its public debut at Nasdaq five days ago, shares of Berkeley, California-based clinical-stage immuno-oncology company have traded between a low of $30.60 and a high of $49.25 and are now at $43.01.
Investment analysts at Morgan Stanley (MS) initiated coverage on shares of Dynegy Inc. (DYN) in a note issued to investors on Monday. The firm set an ‘Overweight‘ rating and a $41 price target on the stock. The firm’s price target would suggest a potential upside of 24.60% from the stock’s current price of $32.90.
Dynegy Inc., currently valued at $4.10 billion, has a median Wall Street price target of $38.00 with a high target of $41.00. Approximately 967K shares have changed hands as of 3:26PM EDT, compared to the stock’s average daily volume of 1.75 million.
In the past 52 weeks, shares of Houston, Texas-based company have traded between a low of $25.30 and a high of $36.57 with the 50-day MA and 200-day MA located at $29.00 and $29.89 levels, respectively. Additionally, shares of DYN have a Relative Strength Index (RSI) and MACD indicator of 66.64 and +1.16, respectively.
Dynegy Inc. currently prints a year-to-date return of around 6.49%.
Shares of The Hershey Company (HSY) are down $1.99, or 1.98%, at $98.28, after Nomura analysts today initiated coverage of the name, giving it a ‘Reduce‘ rating and price target of $88.
On valuation measures, HSY shares are currently priced at 26.07x this year’s forecasted earnings, compared to the industry’s $23.51x earnings multiple. Ticker has a forward P/E of 20.64 and t-12 price-to-sales ratio of 2.98. EPS for the same period is $3.77.
In the past 52 weeks, shares of Hershey, Pennsylvania-based confectionery products company have traded between a low of $87.88 and a high of $111.35. Shares are up 1.97% year-over-year ; down 3.04% year-to-date.
Citigroup (C) is out with a report this morning initiating coverage of Splunk, Inc. (SPLK) with a ‘Buy‘ rating and $81 price target, implying 26% expected return.
In the past 52 weeks, shares of SPLK have traded between a low of $39.35 and a high of $74.88 and are now trading at $64.17. Shares are down 3.64% year-over-year ; up 5.87% year-to-date.
RBC Capital Markets initiated shares of Smith & Wesson Holding Corporation (SWHC) with a ‘Sector Perform‘ rating and set a $16 price target on the name. Right now, the stock is sitting at $15.02, a 1.22% loss, and is 60.61% higher year-to-date, compared with an 11.18% gain in the S&P 500.
SWHC closed Friday at $15.21. The company has a total market cap of 807.80 million.